solriamfetol

solriamfetol

« Back to Glossary Index

Solriamfetol (Sunosi) is a non-stimulant wake-promoting medication that was approved in March 2019 by the U.S. FDA for the treatment of sleepiness caused by narcolepsy and obstructive sleep apnea. It is the first dual-acting dopamine and norepinephrine reuptake inhibitor (NDRI) approved to treat excessive daytime sleepiness in adults. Read more about solriamfetol at MedlinePlus.gov HERE and on HF’s Treatment web page HERE.

Synonyms:
Sunosi


Get SomnusNooze, our e-newsletter

Sign up to receive HF updates, news from the world of sleep research, first-person stories, and more.

You will receive and email from (please check your junk/spam folder if needed) to confirm your subscription to our newsletter through MailChimp. You are not subscribed until you confirm. Thank you for your interest in Hypersomnia Foundation!